Literature DB >> 11238193

Rat gap junction connexin-30 inhibits proliferation of glioma cell lines.

F Princen1, P Robe, D Gros, T Jarry-Guichard, J Gielen, M P Merville, V Bours.   

Abstract

Connexins, the structural components of gap junctions, control cell growth and differentiation and are believed to belong to a family of tumour suppressor genes. Studies on connexin localization in brain showed that several of these proteins were expressed in distinct compartments of the brain in a cell-type specific manner, indicating that different gap junctions play specific roles in the physiology of the mammalian brain. In this report, we first cloned rat connexin-30 cDNA from brain and showed that it was expressed in long-term primary culture of rat astrocytes. In order to examine the potential role of connexin-30 in tumour cell proliferation, we transfected the connexin-30 cDNA into two rat glioma cell lines (9L and C6) which have lost its expression. Transfected clones adequately expressed membrane-bound connexin-30 protein. Connexin-30-expressing clones showed slower growth, lower DNA synthesis and reduced proliferation in soft agar as compared with the parental and control cells. We concluded that connexin-30 may also probably be considered as a tumour suppressor in rat gliomas.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238193     DOI: 10.1093/carcin/22.3.507

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  14 in total

1.  Connexin 30 expression inhibits growth of human malignant gliomas but protects them against radiation therapy.

Authors:  Maria Artesi; Jerome Kroonen; Markus Bredel; Minh Nguyen-Khac; Manuel Deprez; Laurent Schoysman; Christophe Poulet; Arnab Chakravarti; Hyunsoo Kim; Denise Scholtens; Tatjana Seute; Bernard Rogister; Vincent Bours; Pierre A Robe
Journal:  Neuro Oncol       Date:  2014-08-25       Impact factor: 12.300

Review 2.  Gap junctions.

Authors:  Morten Schak Nielsen; Lene Nygaard Axelsen; Paul L Sorgen; Vandana Verma; Mario Delmar; Niels-Henrik Holstein-Rathlou
Journal:  Compr Physiol       Date:  2012-07       Impact factor: 9.090

3.  Identification of stage-specific biomarkers in lung adenocarcinoma based on RNA-seq data.

Authors:  Jun Liang; Jing Lv; Zimin Liu
Journal:  Tumour Biol       Date:  2015-04-11

4.  Neuronal Activity Drives Astroglial Connexin 30 in Perisynaptic Processes and Shapes Its Functions.

Authors:  Grégory Ghézali; Flora Vasile; Nathan Curry; Marcus Fantham; Giselle Cheung; Pascal Ezan; Martine Cohen-Salmon; Clemens Kaminski; Nathalie Rouach
Journal:  Cereb Cortex       Date:  2020-03-21       Impact factor: 5.357

5.  Connexin 30 sets synaptic strength by controlling astroglial synapse invasion.

Authors:  Ulrike Pannasch; Dominik Freche; Glenn Dallérac; Grégory Ghézali; Carole Escartin; Pascal Ezan; Martine Cohen-Salmon; Karim Benchenane; Veronica Abudara; Amandine Dufour; Joachim H R Lübke; Nicole Déglon; Graham Knott; David Holcman; Nathalie Rouach
Journal:  Nat Neurosci       Date:  2014-03-02       Impact factor: 24.884

Review 6.  Gap junction and hemichannel-independent actions of connexins on cell and tissue functions--an update.

Authors:  Jade Z Zhou; Jean X Jiang
Journal:  FEBS Lett       Date:  2014-01-14       Impact factor: 4.124

7.  Connexin43 reduces melanoma growth within a keratinocyte microenvironment and during tumorigenesis in vivo.

Authors:  Mark J Ableser; Silvia Penuela; Jack Lee; Qing Shao; Dale W Laird
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

8.  Dexamethasone inhibits the HSV-tk/ ganciclovir bystander effect in malignant glioma cells.

Authors:  Pierre A Robe; Minh Nguyen-Khac; Olivier Jolois; Bernard Rogister; Marie-Paule Merville; Vincent Bours
Journal:  BMC Cancer       Date:  2005-04-02       Impact factor: 4.430

Review 9.  Connexin and pannexin channels in cancer.

Authors:  Jean X Jiang; Silvia Penuela
Journal:  BMC Cell Biol       Date:  2016-05-24       Impact factor: 4.241

10.  Induction of Apoptosis by PQ1, a Gap Junction Enhancer that Upregulates Connexin 43 and Activates the MAPK Signaling Pathway in Mammary Carcinoma Cells.

Authors:  Stephanie N Shishido; Thu A Nguyen
Journal:  Int J Mol Sci       Date:  2016-01-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.